🇺🇸 FDA
Patent

US 10231988

Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof

granted A61KA61K31/7125A61P

Quick answer

US patent 10231988 (Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/7125, A61P, A61P1/16, A61P3/06